What Researchers Did
Researchers reviewed recent experimental and clinical findings on the pathophysiology and acute therapy of high-altitude sickness.
What They Found
They found that azetazolamide's clinical effectiveness and improvement of body gas exchange are largely proven. Dexamethasone significantly reduced symptoms, particularly for cerebral high-altitude edema, compared to placebo, with effects lasting 12 hours. Nifedipine improved oxygenation and reduced pulmonary-arterial pressure in radiologically proven high-altitude edema.
What This Means for Canadian Patients
Canadian patients traveling to high altitudes should be aware of effective treatments like azetazolamide, dexamethasone, and nifedipine for acute altitude sickness. However, consistent acclimatization remains crucial for prevention, as these therapies have limitations, especially in high-altitude hiking.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not detail the specific methodologies or limitations of the individual studies it synthesizes.